Clearstead Advisors’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
RP
Clearstead Advisors's ACLS Position: Q2 2026 in Review
Clearstead Advisors opened a new position in Axcelis (ACLS) in Q2 2026: 25 shares worth $4.74K. The stake represents ﹤0.01% of the portfolio and ranks #2211 among its holdings. This is a return to the name: Clearstead Advisors previously reported a position in ACLS as recently as Q4 2025.
Clearstead Advisors first reported a position in ACLS in Q3 2023 and has held it in 11 quarters since. The position peaked at $57.8K in Q4 2025. 441 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.
- Clearstead Advisors held 25 shares of Axcelis worth $4.74K as of Q2 2026.
- Axcelis was a new Clearstead Advisors position in Q2 2026.
- Axcelis made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #2211 holding.
- Clearstead Advisors first reported a position in Axcelis in Q3 2023 and has held it in 11 quarters since.
- Clearstead Advisors's Axcelis position peaked at $57.8K in Q4 2025.
- 441 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.
Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.